For the seventh week in a row, indicators show that US influenza activity is dropping, but it's still above baseline levels.

GSK and Pfiz­er have set­tled a law­suit al­leg­ing Pfiz­er’s RSV shot Abrys­vo in­fringed GSK’s patents. A Pfiz­er ...

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Pfizer (PFE) and GSK (GSK) settle RSV vaccine patent lawsuit, dismissing the case with prejudice. REad more here.

Scientists aboard Australia’s RSV Nuyina have discovered rare marine life and a jade-colored iceberg during a 60-day ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

More than 190,000 people still sought medical help for acute respiratory infection (ARI), including 30,000 with ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

The death of actor and leading man Val Kilmer is a stark reminder of how one of the most common lung infections in the ...